Disclosure Intervention for People in Treatment for Opioid Use Disorder

Part of paid clinical trials in Wilmington, Delaware.

Sponsor
University of Delaware
Study ID
NCT06458985
Status
Recruiting

Conditions

  • Opioid Use Disorder

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Disclosing Recovery: A Decision Aid and Toolkit — BEHAVIORAL
    The Disclosing Recovery intervention is designed to help people in treatment for opioid use disorder (1) make key decisions regarding disclosure, including whether, why, what, how, and when to disclose, and (2) build skills to disclose, including planning what to say, practicing disclosure, and preparing for negative responses.

Study Details

The goal of this clinical trial is to test a disclosure intervention among people in treatment for opioid use disorder. The main question it aims to answer is whether people who receive a disclosure intervention have better treatment- and recovery-related outcomes one year after receiving the intervention. Participants will complete a brief disclosure intervention designed to help them (1) make key disclosures related to disclosure and (2) build skills to disclose. Researchers will compare results to participants in a waitlist comparator condition, who receive the intervention at the end of the study.

Key Dates

Start date
May 20, 2024
Status verified
Jul 2025
Primary completion
May 1, 2028
Completion
Aug 31, 2028

Study Design

Enrollment
480 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Disclosing Recovery
    Participants complete a one-hour disclosure intervention for people in treatment for opioid use disorder. The intervention is facilitated by a workbook and accompanying worksheet.
  • No Intervention: Waitlist Comparator
    Participants do not complete the disclosure intervention at their baseline appointment. They are given the opportunity to complete the disclosure intervention at their final appointment.

Primary Outcome Measure

Retention in treatment [ Time Frame: 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Brandywine Counseling & Community ServicesWilmingtonDelaware19805
Carly Hill
1-302-401-1397‬

Find similar trials in Wilmington, DE

Related Studies